Here are three main points:
1. The FDA is watching your social media! Companies cannot recommend any use of products considered “off label.”
2. Keep your social media in adherence with what the company claims in its 510k clearance. Mixed messages from sales reps or employees could create a problem.
3. There is a risk with the reward of advertising or promoting your organization on social media. Be careful not to accidentally post something against regulatory requirements.
Read more on ASCs…
Mark Cuban’s healthcare investment outlook: 5 key notes
6 strategies for securing patient health data
9 things to know about MedPAC’s 2015 ASC report
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
